Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
3.
Pediatr Dermatol ; 40(2): 312-314, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36722625

RESUMEN

This study, which aimed to identify distress by sites of hair loss and psychosocial stressors for a pediatric alopecia areata population, enrolled 50 patients (32 females, 18 males, ages 7-17 years) from pediatric dermatology clinics, including a monthly hair disease clinic. Patients completed a 47-question survey. Scalp hair loss was rated as often or always bothersome in 34.7%; eyebrow loss in 24.3%; and eyelash loss in 21.6%, and 6 patients (12%) discontinued a social activity due to hair loss. Referral to behavioral/mental health specialists should be considered to improve psychosocial outcomes.


Asunto(s)
Alopecia Areata , Pestañas , Hipotricosis , Masculino , Femenino , Humanos , Niño , Adolescente , Alopecia Areata/psicología , Alopecia , Encuestas y Cuestionarios
5.
Dermatol Clin ; 39(3): 447-461, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34053597

RESUMEN

Treatment options for hair loss have traditionally been limited to topical and systemic therapies. Systemic therapies for inflammatory hair disorders are often immunosuppressive, and systemic treatment of androgenetic hair loss can cause undesired effects on sexual and reproductive health. Topical agents have a favorable side effect profile compared with systemic therapies, but many topicals have poor transcutaneous absorption, limiting their concentration and action at follicular targets in the dermis.


Asunto(s)
Alopecia , Cabello , Alopecia/tratamiento farmacológico , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...